Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients

Hopital of Melun122 enrolled

Overview

Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.

Study Type

OBSERVATIONAL

Enrollment

122

Conditions

COVID-19 Pneumonia ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

plasmatic SARS-CoV-2 RNA quantificationDIAGNOSTIC_TEST

plasmatic SARS-CoV-2 RNA was quantified by droplet digital PCR

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age above 18 years * in ICU hospitalization * COVID-19 related pneumonia confirmed by PCR Exclusion Criteria: * plasmatic SARS-COV-2 RNA quantification not available * patient's refusal to participate

Locations (1)

Groupe Hospitalier Sud Ile de France, Hôpital de Melun-Sénart

Melun, France

Outcomes

Primary Outcomes

Day 60 mortality

Association between plasmatic SARS-CoV-2 RNA level and mortality

Time frame: 60 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.